Maryland's life sciences and biotechnology companies work around the clock to deliver life-changing medications, therapies, and cures to patients across the country.
As Maryland's Prescription Drug Affordability Board looks to deliver recommendations on lowering prescription drug costs for patients, it is vital that any policies Maryland lawmakers consider to lower prescription drug prices do not come at the expense of patient access to critical medications or life sciences jobs across the state.
Help us protect Maryland patients, critical life sciences jobs, and innovation.
Join us today and send a letter to Maryland lawmakers encouraging them to protect Maryland patients and our local biotechnology ecosystem by ensuring any legislation to lower drug prices does not unintentionally harm the very industry and workers delivering treatments that allow patients to live healthy and productive lives.
Dear Legislator,
As your constituent, I urge you to support and advance policies that protect Maryland patients and life sciences jobs across the state.
Maryland is home to 54,000 life sciences workers, 2,700 life sciences firms, more than 500 biotechnology companies, and 74 federal research labs, including the National Institutes of Health (NIH) and the Food and Drug Administration (FDA).
As Maryland's Prescription Drug Affordability Board looks to deliver recommendations on lowering prescription drug costs for patients, lawmakers must ensure that any proposed legislation does not come at the expense of Maryland's ability to develop, test, and provide lifesaving treatments and cures to patients across the state and country.
It is vital that we protect 54,000 life sciences jobs and thousands of companies across the state that work every day to find cures for debilitating diseases impacting patients and ensure that patients will be able to access the medication they need.
Thank you,
[Name]
